
Patients with bile duct cancer might soon have an additional treatment available to them, thanks to a newly discovered tumor target. Some bile duct cancers are driven by a mutated HER2 gene, which has also been implicated in cancers of the breast, esophagus and prostate, researchers report in a new study. An experimental drug targeting… read on > read on >